Long‐Read Sequencing Unravels the Complexity of Structural Variants in PRKN in Two Individuals with Early‐Onset Parkinson's Disease
Background: PRKN biallelic pathogenic variants are the most common cause of autosomal recessive early-onset Parkinson’s disease (PD). However, the variants responsible for suspected PRKN-PD individuals are not always identified with standard genetic testing. Objectives: Identify the genetic cause in...
Saved in:
Published in | Movement disorders Vol. 39; no. 9; pp. 1647 - 1648 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken, USA
John Wiley & Sons, Inc
01.09.2024
Wiley Subscription Services, Inc Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background: PRKN biallelic pathogenic variants are the most common cause of autosomal recessive early-onset Parkinson’s disease (PD). However, the variants responsible for suspected PRKN-PD individuals are not always identified with standard genetic testing. Objectives: Identify the genetic cause in two siblings with a PRKN-PD phenotype using long-read sequencing (LRS). Methods: The genetic investigation involved standard testing using successively multiple ligation probe amplification (MLPA), Sanger sequencing, targeted sequencing, whole-exome sequencing and LRS. Results: MLPA and targeted sequencing identified one copy of exon four in PRKN but no other variants were identified. Subsequently, LRS unveiled a large deletion encompassing exon 3 to 4 on one allele and a duplication of exon 3 on the second allele; explaining the siblings’ phenotype. MLPA could not identify the balanced rearrangement of exon 3. Conclusions: This study highlights the potential utility of long-read sequencing in the context of unsolved typical PRKN-PD individuals. |
---|---|
Bibliography: | The authors declare that they have no conflicts of interest. Relevant conflicts of interest/financial disclosures Funding agencies This work was supported in part by the Intramural Research Programs of the National Institute on Aging (NIA). This work was also supported by the Fondation pour la Recherche Médicale (FRM, MND202004011718), the Fondation de France, la Fédération pour la Recherche sur le Cerveau (FRC), France‐Parkinson Association, and the French program “Investissements d'avenir” (ANR‐10‐IAIHU‐06). content type line 23 SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 |
ISSN: | 0885-3185 1531-8257 1531-8257 |
DOI: | 10.1002/mds.29914 |